Effects “beyond-cholesterol” by statins: a 3-months therapy with simvastatin reduces the atherogenic lipoproteins in patients with premature coronary artery disease and in absence of the traditional cardiovascular risk factors.
Authors: RIZZO M; BARBAGALLO CM; PERNICE V; RUBINO A; NOTO D; PACE A; AMATO S; CAMARDA C; PINTO V; PIERI D; FRASHERI A; NOTARBARTOLO A; AVERNA MR
